New Oakland Child-Adolescent and Family Center
Pharmaceutical Research
New Oakland offers a Pharmaceutical Research Treatment Line. The goal of this program is to integrate New Oakland's System of Care and the skills of New Oakland's psychiatrists and clinicians with the country's leading pharmaceutical companies. New Oakland's division of Pharmaceutical Research is under the leadership of the Company's Executive Medical Director, Ismail B. Sendi, MD, MS, in conjunction with Kimberly Smith, LMSW, CCRC.
New Oakland is currently participating in several research projects with leading pharmaceutical companies that have contracted with management to study the efficacy of approved psychiatric medications. In addition to working with New Oakland outpatient, FACE to FACE Intensive Outpatient and FACE to FACE Partial Hospital Day Program treatment models at all facilities, New Oakland Pharmaceutical Research may also contract with additional behavioral healthcare providers regionally. There is a growing need for high quality pharmaceutical research studies as evidenced by New Oakland being approached frequently to provide sites for psycho-pharmaceutical research.
New Oakland Child-Adolescent and Family Center assesses and treats the mental health issues and crises faced by children and adolescents. Immediate action can return well-being to your family. See the "Contact" tab for the nearest New Oakland facility or call the 24 Hour Crisis Stabilization Hot Line: (800) 395-3223.
